Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,546 | -1,617 | -7,679 | -5,740 | -3,932 |
| Depreciation Amortization | 37 | 20 | 80 | 60 | 40 |
| Accounts receivable | 53 | 29 | 30 | 79 | 68 |
| Other Working Capital | 120 | 185 | 702 | 518 | 461 |
| Other Operating Activity | 6,042 | 240 | 1,372 | 980 | 778 |
| Operating Cash Flow | $-2,293 | $-1,143 | $-5,495 | $-4,104 | $-2,585 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,250 | 2,000 | 5,500 | 4,000 | 2,500 |
| Common Stock Repurchased | N/A | N/A | -4 | N/A | N/A |
| Other Financing Activity | 2 | -61 | 38 | -29 | -47 |
| Financing Cash Flow | $3,252 | $1,939 | $5,534 | $3,971 | $2,453 |
| Beginning Cash Position | 172 | 172 | 132 | -132 | 132 |
| End Cash Position | 1,131 | 968 | 172 | N/A | 0 |
| Net Cash Flow | $959 | $796 | $40 | $-132 | $-132 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,293 | -1,143 | -5,495 | -4,104 | -2,585 |
| Free Cash Flow | -2,293 | -1,143 | -5,495 | -4,104 | -2,585 |